CRMAX vs. GENIX

Last updated Jun 23, 2026

CRMAX (CRM Small/Mid Cap Value Fund) and GENIX (Gotham Enhanced Return Fund) are both Mid Cap Blend Equities funds. Over the past 10 years, CRMAX returned 11.62%/yr vs 13.82%/yr for GENIX. A 0.79 correlation means they provide meaningful diversification when combined. CRMAX charges 1.19%/yr vs 1.50%/yr for GENIX.

Performance

CRMAX vs. GENIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CRM Small/Mid Cap Value Fund (CRMAX) and Gotham Enhanced Return Fund (GENIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRMAX achieves a 23.20% return, which is significantly higher than GENIX's 12.07% return. Over the past 10 years, CRMAX has underperformed GENIX with an annualized return of 11.62%, while GENIX has yielded a comparatively higher 13.82% annualized return.

CRMAX

• 1D: 2.73%
• 1M: 7.95%
• YTD: 23.20%
• 6M: 20.60%
• 1Y: 43.35%
• 3Y*: 16.87%
• 5Y*: 8.95%
• 10Y*: 11.62%

GENIX

• 1D: 0.31%
• 1M: 0.67%
• YTD: 12.07%
• 6M: 11.61%
• 1Y: 26.94%
• 3Y*: 24.74%
• 5Y*: 18.30%
• 10Y*: 13.82%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRMAX vs. GENIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CRMAX CRM Small/Mid Cap Value Fund	23.20%	3.89%	16.52%	8.77%	-10.82%	26.46%	13.02%	25.69%	-7.84%	13.97%
GENIX Gotham Enhanced Return Fund	12.07%	21.16%	27.31%	25.26%	-12.02%	39.66%	-8.21%	21.54%	-5.97%	18.21%

Correlation

The correlation between CRMAX and GENIX is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.71
Correlation (3Y) Calculated over the trailing 3-year period	0.72
Correlation (5Y) Calculated over the trailing 5-year period	0.77
Correlation (10Y) Calculated over the trailing 10-year period	0.77
Correlation (All Time) Calculated using the full available price history since Jan 2, 2014	0.79

The correlation between CRMAX and GENIX has been stable across timeframes, ranging from 0.71 to 0.79 - a consistent structural relationship.

Return for Risk

CRMAX vs. GENIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRMAX

CRMAX Risk / Return Rank: 66
CRMAX Sharpe Ratio Rank: 64
CRMAX Sortino Ratio Rank: 67
CRMAX Omega Ratio Rank: 53
CRMAX Calmar Ratio Rank: 79
CRMAX Martin Ratio Rank: 66

GENIX

GENIX Risk / Return Rank: 74
GENIX Sharpe Ratio Rank: 67
GENIX Sortino Ratio Rank: 63
GENIX Omega Ratio Rank: 58
GENIX Calmar Ratio Rank: 89
GENIX Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRMAX vs. GENIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CRM Small/Mid Cap Value Fund (CRMAX) and Gotham Enhanced Return Fund (GENIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CRMAX	GENIX	Difference
Sharpe ratio: Return per unit of total volatility	2.16	2.20	-0.04
Sortino ratio: Return per unit of downside risk	3.10	3.03	+0.07
Omega ratio: Gain probability vs. loss probability	1.37	1.39	-0.02
Calmar ratio: Return relative to maximum drawdown	3.42	4.26	-0.84
Martin ratio: Return relative to average drawdown	11.99	18.01	-6.02

CRMAX vs. GENIX - Sharpe Ratio Comparison

The current CRMAX Sharpe Ratio is 2.16, which is comparable to the GENIX Sharpe Ratio of 2.20. The chart below compares the historical Sharpe Ratios of CRMAX and GENIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CRMAX vs. GENIX - Drawdown Comparison

The maximum CRMAX drawdown since its inception was -49.36%, which is greater than GENIX's maximum drawdown of -39.35%. Use the drawdown chart below to compare losses from any high point for CRMAX and GENIX.

Drawdown Indicators

	CRMAX	GENIX	Difference
Max Drawdown Largest peak-to-trough decline	-49.36%	-39.35%	-10.01%
Max Drawdown (1Y) Largest decline over 1 year	-12.79%	-6.44%	-6.35%
Max Drawdown (3Y) Largest decline over 3 years	-27.73%	-19.20%	-8.53%
Max Drawdown (5Y) Largest decline over 5 years	-27.73%	-20.74%	-6.99%
Max Drawdown (10Y) Largest decline over 10 years	-41.56%	-39.35%	-2.21%
Current Drawdown Current decline from peak	0.00%	-2.14%	+2.14%
Average Drawdown Average peak-to-trough decline	-7.92%	-5.63%	-2.29%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.64%	1.51%	+2.13%

Volatility

CRMAX vs. GENIX - Volatility Comparison

CRM Small/Mid Cap Value Fund (CRMAX) has a higher volatility of 7.81% compared to Gotham Enhanced Return Fund (GENIX) at 4.72%. This indicates that CRMAX's price experiences larger fluctuations and is considered to be riskier than GENIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRMAX	GENIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.81%	4.72%	+3.09%
Volatility (6M) Calculated over the trailing 6-month period	15.49%	9.70%	+5.79%
Volatility (1Y) Calculated over the trailing 1-year period	20.21%	12.47%	+7.74%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.23%	17.25%	+2.98%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	20.82%	18.56%	+2.26%

CRMAX vs. GENIX - Expense Ratio Comparison

CRMAX has a 1.19% expense ratio, which is lower than GENIX's 1.50% expense ratio.

Dividends

CRMAX vs. GENIX - Dividend Comparison

CRMAX's dividend yield for the trailing twelve months is around 4.25%, more than GENIX's 1.85% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CRMAX CRM Small/Mid Cap Value Fund	4.25%	5.23%	15.07%	0.64%	6.41%	35.31%	5.86%	2.68%	18.13%	29.30%	2.13%	12.11%
GENIX Gotham Enhanced Return Fund	1.85%	2.07%	19.28%	9.82%	8.02%	19.31%	0.14%	32.49%	9.60%	0.97%	0.00%	1.85%

Frequently Asked Questions

Can I hold both CRMAX and GENIX in my portfolio?

CRMAX and GENIX have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CRMAX or GENIX?

CRMAX has higher volatility (7.81%) compared to GENIX (4.72%). In terms of maximum drawdown, CRMAX dropped -49.36% vs GENIX's -39.35%.

Which has better risk-adjusted returns?

GENIX currently has the higher Sharpe Ratio (2.20 vs 2.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.